title: Cost-effectiveness of Intensive Blood Pressure Management-Is There an Additional Price to Pay?-Reply.
authors.affiliation: Department of Medicine, Yale University School of Medicine, New Haven, Connecticut.
authors.forename: Ilana B
authors.initials: IB
authors.lastname: Richman
authors.affiliation: Palo Alto Veterans Affairs Health Care System, Palo Alto, California3Center for Health Policy/Center for Primary Care and Outcomes Research, Department of Medicine, Stanford University School of Medicine, Stanford, California.
authors.forename: Douglas K
authors.initials: DK
authors.lastname: Owens
authors.affiliation: Center for Health Policy/Center for Primary Care and Outcomes Research, Department of Medicine, Stanford University School of Medicine, Stanford, California.
authors.forename: Jeremy
authors.initials: J
authors.lastname: Goldhaber-Fiebert
mesh_terms: D000959:Antihypertensive Agents; D001794:Blood Pressure / Q000187:drug effects; D003362:Cost-Benefit Analysis; D006801:Humans; D006973:Hypertension
chemical_list: D000959:Antihypertensive Agents